According to Latest Study , the global market for Human Plasma-derived Hyperimmune Product should grow from US$ 1867 million in 2023 to US$ 2839.8 million by 2030, with a CAGR of 6.2% for the period of 2024-2030.

China Human Plasma-derived Hyperimmune Product market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Human Plasma-derived Hyperimmune Product market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Hepatitis B Immunoglobulins segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Government Institution has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.

The global key manufacturers of Human Plasma-derived Hyperimmune Product include CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG and Hualan Bio, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

This report aims to provide a comprehensive study of the global market for Human Plasma-derived Hyperimmune Product. Report Highlights:

(1) Global Human Plasma-derived Hyperimmune Product market size (sales volume & revenue), history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Human Plasma-derived Hyperimmune Product market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(3) China Human Plasma-derived Hyperimmune Product market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(4) Global Human Plasma-derived Hyperimmune Product segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Human Plasma-derived Hyperimmune Product segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Human Plasma-derived Hyperimmune Product, capacity, production and trends.

(7) Human Plasma-derived Hyperimmune Product industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Hepatitis B Immunoglobulins

Rabies Immunoglobulins

Tetanus Immunoglobulins

Rho(D) Immunoglobulins

Other

Market segment by application, can be divided into

Government Institution

Private Sector

Others

Market segment by players, this report covers

CSL Behring

Grifols

Biotest

Kedrion

CBPO

Emergent (Cangene)

Kamada

CNBG

Hualan Bio

Shanghai RAAS

Sichuan Yuanda Shuyang

ADMA Biologics

1 Market Overview

1.1 Human Plasma-derived Hyperimmune Product Definition

1.2 Global Human Plasma-derived Hyperimmune Product Market Size and Forecast

1.2.1 By Revenue, Global Human Plasma-derived Hyperimmune Product Market Size, 2019-2030

1.2.2 By Sales Volume, Global Human Plasma-derived Hyperimmune Product Market Size, 2019-2030

1.2.3 Global Human Plasma-derived Hyperimmune Product Price Trend, 2019-2030

1.3 China Human Plasma-derived Hyperimmune Product Market Size and Forecast

1.3.1 By Revenue, China Human Plasma-derived Hyperimmune Product Market Size, 2019-2030

1.3.2 By Sales Volume, China Human Plasma-derived Hyperimmune Product Market Size, 2019-2030

1.3.3 China Human Plasma-derived Hyperimmune Product Price Trend, 2019-2030

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Human Plasma-derived Hyperimmune Product Share in Global Market, 2019-2030

1.4.2 By Sales Volume, China Human Plasma-derived Hyperimmune Product Share in Global Market, 2019-2030

1.4.3 Human Plasma-derived Hyperimmune Product Market Size: China VS Global, 2019-2030

1.5 Human Plasma-derived Hyperimmune Product Market Dynamics

1.5.1 Human Plasma-derived Hyperimmune Product Market Drivers

1.5.2 Human Plasma-derived Hyperimmune Product Market Restraints

1.5.3 Human Plasma-derived Hyperimmune Product Industry Trends

1.5.4 Human Plasma-derived Hyperimmune Product Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Human Plasma-derived Hyperimmune Product Revenue by Company, 2019-2024

2.2 Global Human Plasma-derived Hyperimmune Product Sales Volume by Company, 2019-2024

2.3 Global Human Plasma-derived Hyperimmune Product Price by Company, 2019-2024

2.4 Global Human Plasma-derived Hyperimmune Product Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Human Plasma-derived Hyperimmune Product Concentration Ratio

2.6 Global Human Plasma-derived Hyperimmune Product Mergers & Acquisitions, Expansion Plans

2.7 Global Human Plasma-derived Hyperimmune Product Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Human Plasma-derived Hyperimmune Product Revenue by Company, 2019-2024

3.2 China Human Plasma-derived Hyperimmune Product Sales Volume by Company, 2019-2024

3.3 China Human Plasma-derived Hyperimmune Product Human Plasma-derived Hyperimmune Product Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Human Plasma-derived Hyperimmune Product Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)

3.5 Chinese Local Players, Human Plasma-derived Hyperimmune Product Domestic VS Export

3.6 China Market, Human Plasma-derived Hyperimmune Product Import & Export

3.6.1 China Market, Human Plasma-derived Hyperimmune Product Import & Export, 2019-2030

3.6.2 China Human Plasma-derived Hyperimmune Product Import & Export Trends

3.6.3 Main Sources of China Human Plasma-derived Hyperimmune Product Import

3.6.4 Export Destination of China Human Plasma-derived Hyperimmune Product

4 Human Plasma-derived Hyperimmune Product Production by Region

4.1 Global Human Plasma-derived Hyperimmune Product Capacity, Production and Capacity Utilization, 2019-2030

4.2 Global Geographic Distribution of Human Plasma-derived Hyperimmune Product Manufacturers

4.3 Global Major Manufacturers, Human Plasma-derived Hyperimmune Product Capacity Expansion and Future Plans

4.4 Global Human Plasma-derived Hyperimmune Product Capacity by Region

4.5 Global Human Plasma-derived Hyperimmune Product Production by Region

4.5.1 Global Human Plasma-derived Hyperimmune Product Production & Forecast by Region, 2019 VS 2023 VS 2030

4.5.2 Global Human Plasma-derived Hyperimmune Product Production by Region, 2019-2024

4.5.3 Global Human Plasma-derived Hyperimmune Product Production Market Share & Forecast by Region, 2019-2030

5 Industry Chain Analysis

5.1 Human Plasma-derived Hyperimmune Product Industry Chain

5.2 Human Plasma-derived Hyperimmune Product Upstream Analysis

5.2.1 Human Plasma-derived Hyperimmune Product Core Raw Materials

5.2.2 Main Manufacturers of Human Plasma-derived Hyperimmune Product Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Human Plasma-derived Hyperimmune Product Production Mode

5.6 Human Plasma-derived Hyperimmune Product Procurement Model

5.7 Human Plasma-derived Hyperimmune Product Industry Sales Model and Sales Channels

5.7.1 Human Plasma-derived Hyperimmune Product Sales Model

5.7.2 Human Plasma-derived Hyperimmune Product Typical Distributors

6 Sights by Type

6.1 Human Plasma-derived Hyperimmune Product Classification

6.1.1 Hepatitis B Immunoglobulins

6.1.2 Rabies Immunoglobulins

6.1.3 Tetanus Immunoglobulins

6.1.4 Rho(D) Immunoglobulins

6.1.5 Other

6.2 By Type, Global Human Plasma-derived Hyperimmune Product Market Size & CAGR, 2019 VS 2023 VS 2030

6.3 By Type, Global Human Plasma-derived Hyperimmune Product Revenue, 2019-2030

6.4 By Type, Global Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030

6.5 By Type, Global Human Plasma-derived Hyperimmune Product Price, 2019-2030

7 Sights by Application

7.1 Human Plasma-derived Hyperimmune Product Segment by Application

7.1.1 Government Institution

7.1.2 Private Sector

7.1.3 Others

7.2 By Application, Global Human Plasma-derived Hyperimmune Product Market Size & CAGR, 2019 VS 2023 VS 2030

7.3 By Application, Global Human Plasma-derived Hyperimmune Product Revenue, 2019-2030

7.4 By Application, Global Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030

7.5 By Application, Global Human Plasma-derived Hyperimmune Product Price, 2019-2030

8 Sales Sights by Region

8.1 By Region, Global Human Plasma-derived Hyperimmune Product Market Size, 2019 VS 2023 VS 2030

8.2 By Region, Global Human Plasma-derived Hyperimmune Product Revenue, 2019-2030

8.3 By Region, Global Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030

8.4 North America

8.4.1 North America Human Plasma-derived Hyperimmune Product Market Size & Forecasts, 2019-2030

8.4.2 By Country, North America Human Plasma-derived Hyperimmune Product Market Size Market Share

8.5 Europe

8.5.1 Europe Human Plasma-derived Hyperimmune Product Market Size & Forecasts, 2019-2030

8.5.2 By Country, Europe Human Plasma-derived Hyperimmune Product Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Human Plasma-derived Hyperimmune Product Market Size & Forecasts, 2019-2030

8.6.2 By Country/Region, Asia Pacific Human Plasma-derived Hyperimmune Product Market Size Market Share

8.7 South America

8.7.1 South America Human Plasma-derived Hyperimmune Product Market Size & Forecasts, 2019-2030

8.7.2 By Country, South America Human Plasma-derived Hyperimmune Product Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Human Plasma-derived Hyperimmune Product Market Size & CAGR，2019 VS 2023 VS 2030

9.2 By Country, Global Human Plasma-derived Hyperimmune Product Revenue, 2019-2030

9.3 By Country, Global Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030

9.4 U.S.

9.4.1 U.S. Human Plasma-derived Hyperimmune Product Market Size, 2019-2030

9.4.2 By Company, U.S. Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Human Plasma-derived Hyperimmune Product Market Size, Share, 2023 VS 2030

9.4.4 By Application, U.S. Human Plasma-derived Hyperimmune Product Market Size, Share, 2023 VS 2030

9.5 Europe

9.5.1 Europe Human Plasma-derived Hyperimmune Product Market Size, 2019-2030

9.5.2 By Company, Europe Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022

9.5.3 By Type, Europe Human Plasma-derived Hyperimmune Product Market Size, Share, 2023 VS 2030

9.5.4 By Application, Europe Human Plasma-derived Hyperimmune Product Market Size, Share, 2023 VS 2030

9.6 China

9.6.1 China Human Plasma-derived Hyperimmune Product Market Size, 2019-2030

9.6.2 By Company, China Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022

9.6.3 By Type, China Human Plasma-derived Hyperimmune Product Market Size, Share, 2023 VS 2030

9.6.4 By Application, China Human Plasma-derived Hyperimmune Product Market Size, Share, 2023 VS 2030

9.7 Japan

9.7.1 Japan Human Plasma-derived Hyperimmune Product Market Size, 2019-2030

9.7.2 By Company, Japan Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022

9.7.3 By Type, Japan Human Plasma-derived Hyperimmune Product Market Size, Share, 2023 VS 2030

9.7.4 By Application, Japan Human Plasma-derived Hyperimmune Product Market Size, Share, 2023 VS 2030

9.8 South Korea

9.8.1 South Korea Human Plasma-derived Hyperimmune Product Market Size, 2019-2030

9.8.2 By Company, South Korea Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Human Plasma-derived Hyperimmune Product Market Size, Share, 2023 VS 2030

9.8.4 By Application, South Korea Human Plasma-derived Hyperimmune Product Market Size, Share, 2023 VS 2030

9.9 Southeast Asia

9.9.1 Southeast Asia Human Plasma-derived Hyperimmune Product Market Size, 2019-2030

9.9.2 By Company, Southeast Asia Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Human Plasma-derived Hyperimmune Product Market Size, Share, 2023 VS 2030

9.9.4 By Application, Southeast Asia Human Plasma-derived Hyperimmune Product Market Size, Share, 2023 VS 2030

9.10 India

9.10.1 India Human Plasma-derived Hyperimmune Product Market Size, 2019-2030

9.10.2 By Company, India Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022

9.10.3 By Type, India Human Plasma-derived Hyperimmune Product Market Size, Share, 2023 VS 2030

9.10.4 By Application, India Human Plasma-derived Hyperimmune Product Market Size, Share, 2023 VS 2030

9.11 Middle East & Asia

9.11.1 Middle East & Asia Human Plasma-derived Hyperimmune Product Market Size, 2019-2030

9.11.2 By Company, Middle East & Asia Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Human Plasma-derived Hyperimmune Product Market Size, Share, 2023 VS 2030

9.11.4 By Application, Middle East & Asia Human Plasma-derived Hyperimmune Product Market Size, Share, 2023 VS 2030

10 Manufacturers Profile

10.1 CSL Behring

10.1.1 CSL Behring Company Information, Head Office, Market Area and Industry Position

10.1.2 CSL Behring Human Plasma-derived Hyperimmune Product Models, Specifications and Application

10.1.3 CSL Behring Human Plasma-derived Hyperimmune Product Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.1.4 CSL Behring Company Profile and Main Business

10.1.5 CSL Behring Recent Developments

10.2 Grifols

10.2.1 Grifols Company Information, Head Office, Market Area and Industry Position

10.2.2 Grifols Human Plasma-derived Hyperimmune Product Models, Specifications and Application

10.2.3 Grifols Human Plasma-derived Hyperimmune Product Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.2.4 Grifols Company Profile and Main Business

10.2.5 Grifols Recent Developments

10.3 Biotest

10.3.1 Biotest Company Information, Head Office, Market Area and Industry Position

10.3.2 Biotest Human Plasma-derived Hyperimmune Product Models, Specifications and Application

10.3.3 Biotest Human Plasma-derived Hyperimmune Product Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.3.4 Biotest Company Profile and Main Business

10.3.5 Biotest Recent Developments

10.4 Kedrion

10.4.1 Kedrion Company Information, Head Office, Market Area and Industry Position

10.4.2 Kedrion Human Plasma-derived Hyperimmune Product Models, Specifications and Application

10.4.3 Kedrion Human Plasma-derived Hyperimmune Product Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.4.4 Kedrion Company Profile and Main Business

10.4.5 Kedrion Recent Developments

10.5 CBPO

10.5.1 CBPO Company Information, Head Office, Market Area and Industry Position

10.5.2 CBPO Human Plasma-derived Hyperimmune Product Models, Specifications and Application

10.5.3 CBPO Human Plasma-derived Hyperimmune Product Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.5.4 CBPO Company Profile and Main Business

10.5.5 CBPO Recent Developments

10.6 Emergent (Cangene)

10.6.1 Emergent (Cangene) Company Information, Head Office, Market Area and Industry Position

10.6.2 Emergent (Cangene) Human Plasma-derived Hyperimmune Product Models, Specifications and Application

10.6.3 Emergent (Cangene) Human Plasma-derived Hyperimmune Product Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.6.4 Emergent (Cangene) Company Profile and Main Business

10.6.5 Emergent (Cangene) Recent Developments

10.7 Kamada

10.7.1 Kamada Company Information, Head Office, Market Area and Industry Position

10.7.2 Kamada Human Plasma-derived Hyperimmune Product Models, Specifications and Application

10.7.3 Kamada Human Plasma-derived Hyperimmune Product Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.7.4 Kamada Company Profile and Main Business

10.7.5 Kamada Recent Developments

10.8 CNBG

10.8.1 CNBG Company Information, Head Office, Market Area and Industry Position

10.8.2 CNBG Human Plasma-derived Hyperimmune Product Models, Specifications and Application

10.8.3 CNBG Human Plasma-derived Hyperimmune Product Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.8.4 CNBG Company Profile and Main Business

10.8.5 CNBG Recent Developments

10.9 Hualan Bio

10.9.1 Hualan Bio Company Information, Head Office, Market Area and Industry Position

10.9.2 Hualan Bio Human Plasma-derived Hyperimmune Product Models, Specifications and Application

10.9.3 Hualan Bio Human Plasma-derived Hyperimmune Product Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.9.4 Hualan Bio Company Profile and Main Business

10.9.5 Hualan Bio Recent Developments

10.10 Shanghai RAAS

10.10.1 Shanghai RAAS Company Information, Head Office, Market Area and Industry Position

10.10.2 Shanghai RAAS Human Plasma-derived Hyperimmune Product Models, Specifications and Application

10.10.3 Shanghai RAAS Human Plasma-derived Hyperimmune Product Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.10.4 Shanghai RAAS Company Profile and Main Business

10.10.5 Shanghai RAAS Recent Developments

10.11 Sichuan Yuanda Shuyang

10.11.1 Sichuan Yuanda Shuyang Company Information, Head Office, Market Area and Industry Position

10.11.2 Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Models, Specifications and Application

10.11.3 Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.11.4 Sichuan Yuanda Shuyang Company Profile and Main Business

10.11.5 Sichuan Yuanda Shuyang Recent Developments

10.12 ADMA Biologics

10.12.1 ADMA Biologics Company Information, Head Office, Market Area and Industry Position

10.12.2 ADMA Biologics Human Plasma-derived Hyperimmune Product Models, Specifications and Application

10.12.3 ADMA Biologics Human Plasma-derived Hyperimmune Product Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.12.4 ADMA Biologics Company Profile and Main Business

10.12.5 ADMA Biologics Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Human Plasma-derived Hyperimmune Product Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Human Plasma-derived Hyperimmune Product Market Restraints

Table 3. Human Plasma-derived Hyperimmune Product Market Trends

Table 4. Human Plasma-derived Hyperimmune Product Industry Policy

Table 5. Global Human Plasma-derived Hyperimmune Product Revenue by Company, 2019-2024, US$ million

Table 6. Global Human Plasma-derived Hyperimmune Product Revenue Market Share by Company, 2019-2024

Table 7. Global Human Plasma-derived Hyperimmune Product Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global Human Plasma-derived Hyperimmune Product Sales Volume Market Share by Company, 2019-2024

Table 9. Global Human Plasma-derived Hyperimmune Product Price by Company, 2019-2024, (US$/Unit)

Table 10. Global Human Plasma-derived Hyperimmune Product Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Human Plasma-derived Hyperimmune Product Mergers & Acquisitions, Expansion Plans

Table 12. Global Human Plasma-derived Hyperimmune Product Manufacturers Product Type

Table 13. China Human Plasma-derived Hyperimmune Product Revenue by Company, 2019-2024, US$ million

Table 14. China Human Plasma-derived Hyperimmune Product Revenue Market Share by Company, 2019-2024

Table 15. China Human Plasma-derived Hyperimmune Product Sales Volume by Company, 2019-2024, (K Units)

Table 16. China Human Plasma-derived Hyperimmune Product Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, Human Plasma-derived Hyperimmune Product Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Human Plasma-derived Hyperimmune Product Import & Export Trends

Table 19. Main Sources of China Human Plasma-derived Hyperimmune Product Import

Table 20. Export Destination of China Human Plasma-derived Hyperimmune Product

Table 21. Global Headquarters and Manufacturing Base of Human Plasma-derived Hyperimmune Product Manufacturers

Table 22. Global Major Manufacturers, Human Plasma-derived Hyperimmune Product Capacity Expansion and Future Plans

Table 23. Global Human Plasma-derived Hyperimmune Product Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global Human Plasma-derived Hyperimmune Product Production by Region, 2019-2024, (K Units)

Table 25. Global Human Plasma-derived Hyperimmune Product Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Human Plasma-derived Hyperimmune Product Upstream (Raw Materials)

Table 27. Global Human Plasma-derived Hyperimmune Product Typical Customers

Table 28. Human Plasma-derived Hyperimmune Product Typical Distributors

Table 29. By Type, Global Human Plasma-derived Hyperimmune Product Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global Human Plasma-derived Hyperimmune Product Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global Human Plasma-derived Hyperimmune Product Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global Human Plasma-derived Hyperimmune Product Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Human Plasma-derived Hyperimmune Product Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global Human Plasma-derived Hyperimmune Product Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Human Plasma-derived Hyperimmune Product Revenue Market Share, 2019-2030

Table 37. By Country, Global Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2019-2030

Table 39. CSL Behring Company Information, Head Office, Market Area and Industry Position

Table 40. CSL Behring Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 41. CSL Behring Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. CSL Behring Company Profile and Main Business

Table 43. CSL Behring Recent Developments

Table 44. Grifols Company Information, Head Office, Market Area and Industry Position

Table 45. Grifols Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 46. Grifols Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Grifols Company Profile and Main Business

Table 48. Grifols Recent Developments

Table 49. Biotest Company Information, Head Office, Market Area and Industry Position

Table 50. Biotest Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 51. Biotest Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Biotest Company Profile and Main Business

Table 53. Biotest Recent Developments

Table 54. Kedrion Company Information, Head Office, Market Area and Industry Position

Table 55. Kedrion Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 56. Kedrion Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Kedrion Company Profile and Main Business

Table 58. Kedrion Recent Developments

Table 59. CBPO Company Information, Head Office, Market Area and Industry Position

Table 60. CBPO Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 61. CBPO Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. CBPO Company Profile and Main Business

Table 63. CBPO Recent Developments

Table 64. Emergent (Cangene) Company Information, Head Office, Market Area and Industry Position

Table 65. Emergent (Cangene) Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 66. Emergent (Cangene) Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Emergent (Cangene) Company Profile and Main Business

Table 68. Emergent (Cangene) Recent Developments

Table 69. Kamada Company Information, Head Office, Market Area and Industry Position

Table 70. Kamada Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 71. Kamada Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Kamada Company Profile and Main Business

Table 73. Kamada Recent Developments

Table 74. CNBG Company Information, Head Office, Market Area and Industry Position

Table 75. CNBG Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 76. CNBG Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. CNBG Company Profile and Main Business

Table 78. CNBG Recent Developments

Table 79. Hualan Bio Company Information, Head Office, Market Area and Industry Position

Table 80. Hualan Bio Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 81. Hualan Bio Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Hualan Bio Company Profile and Main Business

Table 83. Hualan Bio Recent Developments

Table 84. Shanghai RAAS Company Information, Head Office, Market Area and Industry Position

Table 85. Shanghai RAAS Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 86. Shanghai RAAS Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Shanghai RAAS Company Profile and Main Business

Table 88. Shanghai RAAS Recent Developments

Table 89. Sichuan Yuanda Shuyang Company Information, Head Office, Market Area and Industry Position

Table 90. Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 91. Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. Sichuan Yuanda Shuyang Company Profile and Main Business

Table 93. Sichuan Yuanda Shuyang Recent Developments

Table 94. ADMA Biologics Company Information, Head Office, Market Area and Industry Position

Table 95. ADMA Biologics Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 96. ADMA Biologics Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. ADMA Biologics Company Profile and Main Business

Table 98. ADMA Biologics Recent Developments

List of Figure

Figure 1. Human Plasma-derived Hyperimmune Product Picture

Figure 2. By Revenue, Global Human Plasma-derived Hyperimmune Product Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Human Plasma-derived Hyperimmune Product Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Human Plasma-derived Hyperimmune Product Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Human Plasma-derived Hyperimmune Product Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Human Plasma-derived Hyperimmune Product Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Human Plasma-derived Hyperimmune Product Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Human Plasma-derived Hyperimmune Product Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Human Plasma-derived Hyperimmune Product Share of Global Market, 2019-2030

Figure 10. Global Human Plasma-derived Hyperimmune Product Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Human Plasma-derived Hyperimmune Product Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Human Plasma-derived Hyperimmune Product Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Human Plasma-derived Hyperimmune Product Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Human Plasma-derived Hyperimmune Product Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of Human Plasma-derived Hyperimmune Product Domestic VS Export, 2022

Figure 16. Global Human Plasma-derived Hyperimmune Product Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Human Plasma-derived Hyperimmune Product Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Human Plasma-derived Hyperimmune Product Production Market Share & Forecast by Region, 2019-2030

Figure 19. Human Plasma-derived Hyperimmune Product Industry Chain

Figure 20. Human Plasma-derived Hyperimmune Product Procurement Model

Figure 21. Human Plasma-derived Hyperimmune Product Sales Model

Figure 22. Human Plasma-derived Hyperimmune Product Sales Channels, Direct Sales and Distribution

Figure 23. Hepatitis B Immunoglobulins

Figure 24. Rabies Immunoglobulins

Figure 25. Tetanus Immunoglobulins

Figure 26. Rho(D) Immunoglobulins

Figure 27. Other

Figure 28. By Type, Global Human Plasma-derived Hyperimmune Product Revenue, 2019-2030, US$ Million

Figure 29. By Type, Global Human Plasma-derived Hyperimmune Product Revenue Market Share, 2019-2030

Figure 30. By Type, Global Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Figure 31. By Type, Global Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2019-2030

Figure 32. By Type, Global Human Plasma-derived Hyperimmune Product Price, 2019-2030, (US$/Unit)

Figure 33. Government Institution

Figure 34. Private Sector

Figure 35. Others

Figure 36. By Application, Global Human Plasma-derived Hyperimmune Product Revenue, 2019-2030, US$ Million

Figure 37. By Application, Global Human Plasma-derived Hyperimmune Product Revenue Market Share, 2019-2030

Figure 38. By Application, Global Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Figure 39. By Application, Global Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2019-2030

Figure 40. By Application, Global Human Plasma-derived Hyperimmune Product Price, 2019-2030, (US$/Unit)

Figure 41. By Region, Global Human Plasma-derived Hyperimmune Product Revenue Market Share, 2019-2030

Figure 42. By Region, Global Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2019-2030

Figure 43. North America Human Plasma-derived Hyperimmune Product Revenue & Forecasts, 2019-2030, US$ Million

Figure 44. By Country, North America Human Plasma-derived Hyperimmune Product Revenue Market Share, 2022

Figure 45. Europe Human Plasma-derived Hyperimmune Product Revenue & Forecasts, 2019-2030, US$ Million

Figure 46. By Country, Europe Human Plasma-derived Hyperimmune Product Revenue Market Share, 2022

Figure 47. Asia Pacific Human Plasma-derived Hyperimmune Product Revenue & Forecasts, 2019-2030, US$ Million

Figure 48. By Country/Region, Asia Pacific Human Plasma-derived Hyperimmune Product Revenue Market Share, 2022

Figure 49. South America Human Plasma-derived Hyperimmune Product Revenue & Forecasts, 2019-2030, US$ Million

Figure 50. By Country, South America Human Plasma-derived Hyperimmune Product Revenue Market Share, 2022

Figure 51. Middle East & Africa Human Plasma-derived Hyperimmune Product Revenue & Forecasts, 2019-2030, US$ Million

Figure 52. U.S. Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Figure 53. By Company, U.S. Human Plasma-derived Hyperimmune Product Market Share, 2022

Figure 54. By Type, U.S. Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 55. By Application, U.S. Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 56. Europe Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Figure 57. By Company, Europe Human Plasma-derived Hyperimmune Product Market Share, 2022

Figure 58. By Type, Europe Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 59. By Application, Europe Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 60. China Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Figure 61. By Company, China Human Plasma-derived Hyperimmune Product Market Share, 2022

Figure 62. By Type, China Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 63. By Application, China Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 64. Japan Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Figure 65. By Company, Japan Human Plasma-derived Hyperimmune Product Market Share, 2022

Figure 66. By Type, Japan Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 67. By Application, Japan Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 68. South Korea Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Figure 69. By Company, South Korea Human Plasma-derived Hyperimmune Product Market Share, 2022

Figure 70. By Type, South Korea Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 71. By Application, South Korea Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 72. Southeast Asia Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Figure 73. By Company, Southeast Asia Human Plasma-derived Hyperimmune Product Market Share, 2022

Figure 74. By Type, Southeast Asia Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 75. By Application, Southeast Asia Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 76. India Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Figure 77. By Company, India Human Plasma-derived Hyperimmune Product Market Share, 2022

Figure 78. By Type, India Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 79. By Application, India Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 80. Middle East & Asia Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Figure 81. By Company, Middle East & Asia Human Plasma-derived Hyperimmune Product Market Share, 2022

Figure 82. By Type, Middle East & Asia Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 83. By Application, Middle East & Asia Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 84. Research Methodology

Figure 85. Breakdown of Primary Interviews

Figure 86. Bottom-up Approaches

Figure 87. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)